Dimethyl n-methylsulfamide
|
- $45 - $1249
- Product name: Dimethyl n-methylsulfamide
- CAS: 76820-42-3
- MF: C3H10N2O2S
- MW: 138.19
- EINECS:
- MDL Number:MFCD02860319
- Synonyms:Dimethyl n-methylsulfamide;Sulfamide, trimethyl-;dimethyl(methylsulfamoyl)amine;Sulfamide, N,N,N'-trimethyl-
5 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 100mg
- 500mg
- 1g
- 25g
- 100g
- ManufacturerAK Scientific
- Product numberV9965
- Product description(Dimethylsulfamoyl)methylamine
- Packaging1g
- Price$112
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13004765
- Product descriptionDimethylN-Methylsulfamide 95+%
- Packaging100g
- Price$1249
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13004765
- Product descriptionDimethylN-Methylsulfamide 95+%
- Packaging25g
- Price$424
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD478700
- Product descriptiondimethyl(methylsulfamoyl)amine
- Packaging100mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD478700
- Product descriptiondimethyl(methylsulfamoyl)amine
- Packaging500mg
- Price$130
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | V9965 | (Dimethylsulfamoyl)methylamine | 1g | $112 | 2021-12-16 | Buy |
| Crysdot | CD13004765 | DimethylN-Methylsulfamide 95+% | 100g | $1249 | 2021-12-16 | Buy |
| Crysdot | CD13004765 | DimethylN-Methylsulfamide 95+% | 25g | $424 | 2021-12-16 | Buy |
| TRC | D478700 | dimethyl(methylsulfamoyl)amine | 100mg | $45 | 2021-12-16 | Buy |
| TRC | D478700 | dimethyl(methylsulfamoyl)amine | 500mg | $130 | 2021-12-16 | Buy |
Properties
Boiling point :191.3±23.0 °C(Predicted)
Density :1.200±0.06 g/cm3(Predicted)
pka :12.50±0.40(Predicted)
Density :1.200±0.06 g/cm3(Predicted)
pka :12.50±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|